| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 03/15/2001 | WO2001018005A1 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 03/15/2001 | WO2001017952A1 Substituted cyclopentenes, their preparation and their use for chiral scaffolds |
| 03/15/2001 | WO2001017948A1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
| 03/15/2001 | WO2001017947A1 Process for the preparation of 2,3-dihydroazepine compounds |
| 03/15/2001 | WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | CA2384145A1 Process for the preparation of 2,3-dihydroazepine compounds |
| 03/15/2001 | CA2380656A1 Substituted cyclopentenes, their preparation and their use for chiral scaffolds |
| 03/14/2001 | EP1083164A1 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/14/2001 | EP1082291A1 Chemical process for the stereoselective synthesis of r-(-)-carnitine |
| 03/14/2001 | EP1082290A1 Process for the preparation of aceclofenac |
| 03/14/2001 | EP1082121A1 Hiv integrase inhibitors |
| 03/14/2001 | EP0805800B1 Method for preparing (+)compactin and (+)mevinolin analog compounds having a beta-hydroxy-delta-lactone grouping |
| 03/14/2001 | CN1287117A Cycloene derivate, its producing process and its therapeutical use |
| 03/13/2001 | US6201121 Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives |
| 03/13/2001 | US6201023 Methods and compositions to protect crops against plant parasitic nematodes |
| 03/13/2001 | US6200987 Cyclic amides |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/08/2001 | WO2001016211A1 Amphipathic compound having dendritic structure |
| 03/08/2001 | WO2001016117A1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/08/2001 | WO2001016090A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
| 03/08/2001 | DE19941566A1 Stabile (CF3)2N-Salze und Verfahren zu deren Herstellung Stable (CF3) 2N salts and processes for their preparation |
| 03/08/2001 | CA2384191A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
| 03/07/2001 | EP1081129A2 Stable (CF3)2N-Salts, a method of preparing them and their use in the synthesis of liquid crystals |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/07/2001 | CN1286245A Stable (CF3)2N(-) salt and preparing process thereof |
| 03/07/2001 | CN1062855C Method for preparing alkali metal salt of hydroxymethyl-iminodiacetic acid |
| 03/06/2001 | US6197996 Asymmetrically hydrogenating gamma-trimethylammonium-3-oxabutanoic ester halide in presence of ruthenium-optically active phosphine complex as catalyst, recovering optically active carnitine ester formed |
| 03/06/2001 | US6197819 Treatment of seizure disorders. activate gad, bind a novel binding site which was identified to bind tritiated gabapentin. |
| 03/06/2001 | US6197506 Using substrate having over 100 different polynucleotides at density of over 50 different polynucleotides per square centimeter to generate hybridization patterns and distinguish between two nucleic acid samples; heredity; diagnosis |
| 03/06/2001 | CA2073673C Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |
| 03/01/2001 | WO2001014576A2 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | WO2001014390A2 METABOTROPIC GLUTAMATE RECEPTOR LIGAND DERIVATIVES AS NAALADase INHIBITORS |
| 03/01/2001 | WO2001014315A1 Aminohydroxylation of olefins |
| 03/01/2001 | WO2001014314A1 Benzene derivatives having aromatic substituents and processes for the preparation thereof |
| 03/01/2001 | DE19941062A1 Pure methyl 2-acetamido-3-chloropropionate preparation for use as intermediate for hypotensive agent ramipril, from methyl serinate hydrochloride by chlorination, acetylation and purification |
| 03/01/2001 | CA2376509A1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | CA2317284A1 Stable (cf3)2n-salts and process for preparing them |
| 02/28/2001 | EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1062552C Cyclohexadiene derivatives, pharmaceuticals contg. same, prepn. method and use thereof |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2379431A1 Targeted lipid particles |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/20/2001 | US6191306 Using 5-step process wherein cyclopropanecarboxaldehyde is reacted with a-aminoalkylaromatic compound to obtain imine which is reacted with cyanide to produce aminonitrile which is hydrolyzed to the corresponding acid which is hydrogenated |
| 02/20/2001 | US6191262 Contrast agent preparation |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/15/2001 | WO2001010819A1 Nitroxy derivatives of (r) and (s)-carnitine |
| 02/15/2001 | WO2001010818A1 Process for preparing betaines |
| 02/15/2001 | CA2380856A1 Process for preparing betaines |
| 02/15/2001 | CA2379047A1 Nitroxy derivatives of (r) and (s)-carnitine |
| 02/14/2001 | EP1076052A2 L-Asparate solution and a storage and/or transportation method thereof |
| 02/14/2001 | EP1075461A2 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 02/14/2001 | CN1283615A New Process and intermediate |
| 02/13/2001 | US6187938 Transdermal penetration enhancers |
| 02/13/2001 | US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use |
| 02/08/2001 | WO2001009117A1 Tricyclic compounds as glycine transport inhibitors |
| 02/08/2001 | WO2001009084A1 Process for the preparation of cyclopropylglycine |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/07/2001 | EP1073641A2 New substituted amides, their production and their use |
| 02/07/2001 | EP1073625A1 Tilidine mesylate, processes for its preparation and pharmaceutical composition thereof |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073623A1 Substituted amino acids as erythropoietin mimetics |
| 02/07/2001 | EP1073613A2 Main-group metal-based asymmetric catalysts and applications thereof |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283178A Processes for producing beta-halogenno-alpha, -amino-carboxylic acids and phenylcy steine derivatives and intermediates thereof |
| 02/07/2001 | CN1282732A 'alpha'-hydroxy-'beta' amino acid ester and its preparation method |
| 02/07/2001 | CN1282731A Process for preparing alpha, omega, delta-tribenzyloxycarbonyl arginine |
| 02/07/2001 | CN1282730A Compounds with particular structure and anticancer activity and its preparing process |
| 02/06/2001 | US6184345 Stable under solid phase synthesis conditions |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007399A1 In-situ preparation of polyaspartic ester mixture |
| 02/01/2001 | WO2001007040A1 Multidrug-resistant cancer overcoming agents and process for producing the same |
| 02/01/2001 | CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients |
| 01/31/2001 | EP1072584A1 Amine derivative fixed to resin and method for synthesizing beta-aminocarbonyl compound in a solid phase |
| 01/31/2001 | EP1072583A1 2-methylpropionic acid derivatives and medicinal compositions containing the same |
| 01/31/2001 | EP1072579A2 Method for producing aromatic carboxylic acid compounds |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071655A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 01/31/2001 | EP1071645A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds |
| 01/31/2001 | CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 01/30/2001 | US6180667 Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock |
| 01/30/2001 | US6180374 Method for preparing tert-leucine and analogues thereof in enantiomeric form and intermediates therein |
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | CA1341173C Fungicides |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005741A1 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds |
| 01/25/2001 | WO2000066550A8 New compounds |
| 01/25/2001 | CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/24/2001 | EP1070726A1 Aspartyl dipeptide ester derivatives and sweeteners |
| 01/24/2001 | EP1070703A1 Cyclobutene derivatives |
| 01/24/2001 | EP1070046A1 Propanolamine derivatives |